Holen Sie sich die Stockscreener-App
3.54
3.81%
0.13
Handel nachbörslich:
3.54
Schlusskurs vom Vortag:
$3.41
Offen:
$3.46
24-Stunden-Volumen:
7,844
Relative Volume:
0.03
Marktkapitalisierung:
$4.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.35M
KGV:
-2.4414
EPS:
-1.45
Netto-Cashflow:
$-36.91M
1W Leistung:
+3.21%
1M Leistung:
+10.62%
6M Leistung:
-37.89%
1J Leistung:
-69.32%
1-Tages-Spanne:
$3.40
$3.54
1-Wochen-Bereich:
$3.10
$3.65
52-Wochen-Spanne:
$2.01
$16.07
Galecto Inc Stock (GLTO) Company Profile
Firmenname
Galecto Inc
Sektor
Branche
Telefon
45-70-70-52-10
Adresse
75 STATE STREET, BOSTON
Vergleichen Sie GLTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
3.54 | 4.44M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-11-23 | Eingeleitet | BofA Securities | Buy |
| 2020-11-23 | Eingeleitet | Credit Suisse | Outperform |
| 2020-11-23 | Eingeleitet | SVB Leerink | Outperform |
Galecto Inc Aktie (GLTO) Neueste Nachrichten
12,701 Shares in Galecto, Inc. (NASDAQ:GLTO) Bought by Squarepoint Ops LLC - Defense World
Galecto (NASDAQ:GLTO) Shares Down 3.4% – What’s Next? - Defense World
Galecto Reports First Quarter 2025 Operating and Financial Results - The Manila Times
Galecto Reports First Quarter 2025 Operating and Financial Resul - GuruFocus
Galecto Reports First Quarter 2025 Operating and Financial Results | GLTO Stock News - GuruFocus
Renaissance Technologies LLC Sells 6,338 Shares of Galecto, Inc. (NASDAQ:GLTO) - Defense World
Keppel DC REIT (OTCMKTS:KPDCF) Short Interest Up 133.4% in March - Defense World
Galecto, Inc. (NASDAQ:GLTO) Short Interest Up 133.6% in March - Defense World
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - benzinga.com
Galecto, Inc. Focuses on Oncology and Liver Diseases - TipRanks
Galecto stock hits 52-week low at $3.75 amid market challenges - Investing.com
Galecto stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa
Galecto stock hits 52-week low at $4.39 amid market challenges - MSN
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Galecto (GLTO) Shares Rally Amid Positive Market Momentum - Stocks Telegraph
Galecto Reports Full-Year 2024 Financial Results - The Manila Times
Galecto Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Galecto, Inc. Completes Strategic Review, Acquires Global Rights to GB3226 for Oncology and Liver Disease Focus - Nasdaq
Galecto Cuts Losses by $17M, Acquires Promising AML Drug Candidate - StockTitan
Galecto Inc expected to post a loss of $2.97 a shareEarnings Preview - TradingView
Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approvals, Therapies, Mechanism of Action, Route of Administration & Companies by DelveInsight - The Globe and Mail
Galecto stock plunges to 52-week low at $3.76 amid market challenges - Investing.com Australia
Galecto stock plunges to 52-week low at $3.76 amid market challenges By Investing.com - Investing.com South Africa
Galecto (GLTO) Projected to Post Quarterly Earnings on Friday - Defense World
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Galecto stock hits 52-week low at $4.20 amid market challenges - Investing.com Australia
Galecto stock hits 52-week low at $4.20 amid market challenges By Investing.com - Investing.com South Africa
Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World
Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World
Galecto to Participate in Upcoming Investor Conferences - The Globe and Mail
Galecto stock hits 52-week low at $4.39 amid market challenges By Investing.com - Investing.com South Africa
Leerink Partnrs Estimates Galecto FY2024 Earnings - Defense World
Brokers Set Expectations for Galecto FY2029 Earnings - Armenian Reporter
Galecto to Participate in Upcoming Investor Conferences -February 06, 2025 at 08:01 am EST - Marketscreener.com
Biotech Spotlight: Galecto Lines Up Triple Conference Showcase for Investors - StockTitan
Where are the Opportunities in (GLTO) - Stock Traders Daily
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Critical Analysis: Galecto (NASDAQ:GLTO) vs. ObsEva (NASDAQ:OBSV) - Defense World
Finanzdaten der Galecto Inc-Aktie (GLTO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Galecto Inc-Aktie (GLTO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Firmani Lori | Interim CFO |
Jan 03 '25 |
Sale |
5.63 |
261 |
1,469 |
465 |
| Schambye Hans T. | Chief Executive Officer |
Jan 03 '25 |
Sale |
5.60 |
1,341 |
7,510 |
3,397 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):